Meghan . Quinlivan
Megan C. Quinlivan, Esq., is a shareholder in Burg Simpson Eldredge Hersh & Jardine and represents plaintiffs in complex product liability cases involving prescription medications, medical devices and consumer products. Currently, Ms. Quinlivan represents hundreds of people harmed by HIV drugs manufactured by California biotech giant Gilead Sciences, and serves on the Executive Committee for Gilead Tenofovir Cases and Coordinated Actions, California JCCP No. 5043. Ms. Quinlivan earned her law degree from the University of California - Hastings College of the Law. She has been recognized by Best Lawyers in America in 2018 - 2020, and as a National Trial Lawyers Top 100 Trial Lawyer for Colorado each year from 2013-2020.
(09/20)
